ATE386133T1 - Zusammensetzungen der orthogonalen lysyl-trna und aminoacyl-trna synthetase paaren und ihre verwendungen - Google Patents

Zusammensetzungen der orthogonalen lysyl-trna und aminoacyl-trna synthetase paaren und ihre verwendungen

Info

Publication number
ATE386133T1
ATE386133T1 AT06002989T AT06002989T ATE386133T1 AT E386133 T1 ATE386133 T1 AT E386133T1 AT 06002989 T AT06002989 T AT 06002989T AT 06002989 T AT06002989 T AT 06002989T AT E386133 T1 ATE386133 T1 AT E386133T1
Authority
AT
Austria
Prior art keywords
trna
orthogonal
aminoacyl
lysyl
synthetase pair
Prior art date
Application number
AT06002989T
Other languages
English (en)
Inventor
Christopher J Anderson
Ning Wu
Stephen Santoro
Peter G Schultz
Original Assignee
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Inst filed Critical Scripps Research Inst
Application granted granted Critical
Publication of ATE386133T1 publication Critical patent/ATE386133T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT06002989T 2003-07-07 2004-07-07 Zusammensetzungen der orthogonalen lysyl-trna und aminoacyl-trna synthetase paaren und ihre verwendungen ATE386133T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48545103P 2003-07-07 2003-07-07
US52881503P 2003-12-10 2003-12-10
US53714904P 2004-01-15 2004-01-15

Publications (1)

Publication Number Publication Date
ATE386133T1 true ATE386133T1 (de) 2008-03-15

Family

ID=34222340

Family Applications (2)

Application Number Title Priority Date Filing Date
AT06002989T ATE386133T1 (de) 2003-07-07 2004-07-07 Zusammensetzungen der orthogonalen lysyl-trna und aminoacyl-trna synthetase paaren und ihre verwendungen
AT08001573T ATE471385T1 (de) 2003-07-07 2004-07-07 Zusammensetzungen aus orthogonalen lysyl-trna- und aminoacyl-trna-synthetasepaaren und deren verwendung

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT08001573T ATE471385T1 (de) 2003-07-07 2004-07-07 Zusammensetzungen aus orthogonalen lysyl-trna- und aminoacyl-trna-synthetasepaaren und deren verwendung

Country Status (14)

Country Link
US (4) US7638297B2 (de)
EP (2) EP1666604B1 (de)
JP (2) JP5192150B2 (de)
CN (1) CN101076598B (de)
AT (2) ATE386133T1 (de)
AU (1) AU2004267359B2 (de)
BR (1) BRPI0412272A (de)
CA (1) CA2531146A1 (de)
DE (2) DE602004027770D1 (de)
ES (1) ES2301099T3 (de)
MX (1) MXPA06000242A (de)
PT (2) PT1914314E (de)
SI (1) SI1666604T1 (de)
WO (1) WO2005019415A2 (de)

Families Citing this family (148)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL158419A0 (en) * 2001-04-19 2004-05-12 Scripps Research Inst Methods and composition for the production of orthoganal trna-aminoacyl trna synthetase pairs
ES2333422T3 (es) * 2002-10-16 2010-02-22 The Scripps Research Institute Sintesis de glicoproteinas.
EP1613735B1 (de) 2003-04-17 2012-01-25 The Scripps Research Institute Ausweitung des eukaryotischen genetischen codes
EP2410331B1 (de) 2003-06-18 2015-09-23 The Scripps Research Institute Aminoacyl-tRNA Synthetase zur Aminoacylierung von tRNA mit unnatürlichen Aminosäuren
PT1914314E (pt) * 2003-07-07 2010-09-08 Scripps Research Inst Composições de pares ortogonais de lisil-arnt e aminoacil-arnt-sintetase e suas utilizações
JP5657850B2 (ja) 2003-10-14 2015-01-21 ザ スクリプス リサーチ インスティテュート 酸化還元機能性アミノ酸のタンパク質への部位特異的組み入れ
CA2553035A1 (en) 2004-02-02 2005-08-18 Ambrx, Inc. Modified human growth hormone polypeptides and their uses
US7399619B2 (en) 2004-05-25 2008-07-15 The Scripps Research Institute Site specific incorporation of heavy atom-containing unnatural amino acids into proteins for structure determination
JP2008503217A (ja) 2004-06-18 2008-02-07 アンブレツクス・インコーポレイテツド 新規抗原結合ポリペプチド及びそれらの使用
EP1771573A4 (de) 2004-07-21 2009-02-18 Ambrx Inc Nichtnatürliche kodierte aminosäuren verwendende biosynthetische polypeptide
EP2770053B1 (de) 2004-09-21 2018-02-21 The Scripps Research Institute In-vivo-Einbringung von Alkynyl-Aminosäuren in Proteine in Eubakterien
JP2008513806A (ja) * 2004-09-22 2008-05-01 ザ スクリップス リサーチ インスティテュート Ｎｍｒ試験のための蛋白質の部位特異的標識
EP1809758A4 (de) 2004-10-20 2009-04-01 Scripps Research Inst Stellenspezifischer in-vivo-einbau von n-acetylgalactosamin-aminosäuren in eubakterien
US8216804B2 (en) 2004-10-27 2012-07-10 The Scripps Research Institute Orthogonal translation components for the in vivo incorporation of unnatural amino acids
ATE542920T1 (de) 2004-12-22 2012-02-15 Ambrx Inc Modifiziertes menschliches wachstumshormon
BRPI0519170A8 (pt) 2004-12-22 2018-05-08 Ambrx Inc formulações de hormônio de crescimento humano que compreendem um aminoácido não naturalmente codificado
CN102732588B (zh) 2004-12-22 2015-01-07 Ambrx公司 氨酰基-tRNA合成酶的组合物及其用途
BRPI0518661A2 (pt) 2004-12-22 2008-12-02 Ambrx Inc mÉtodos para expressço e purificaÇço do hormânio do crescimento humano recombinante
WO2006133089A2 (en) 2005-06-03 2006-12-14 Ambrx, Inc. Improved human interferon molecules and their uses
BRPI0617191A2 (pt) 2005-10-12 2011-07-19 Scripps Research Inst modificação pós-traducional de polipeptìdeos expressos em fagos
CN101454461A (zh) 2005-11-16 2009-06-10 Ambrx公司 包括非天然氨基酸的方法和组合物
EP1963536B1 (de) 2005-12-22 2016-05-04 Pacific Biosciences of California, Inc. Polymerasen zur nukleotid-analog-einfügung
PL1991680T3 (pl) * 2006-03-09 2014-01-31 Scripps Research Inst Układ do ekspresji ortogonalnych składników translacji w eubakteryjnych komórkach gospodarza
MX2008011669A (es) 2006-03-16 2008-09-22 Scripps Research Inst Expresion programada geneticamente de proteinas que contienen el aminoacido no natural fenilselenocisteina.
EP2018429A4 (de) * 2006-05-23 2010-07-14 Scrips Res Inst Genetisch kodierte fluoreszente cumarin-aminosäuren
WO2008030614A2 (en) 2006-09-08 2008-03-13 Ambrx, Inc. Suppressor trna transcription in vertebrate cells
EP2615108B1 (de) 2006-09-08 2016-10-26 Ambrx, Inc. Modifiziertes humanes Plasmapolypeptid oder Fc-Gerüste und deren Verwendungen
MX2009002987A (es) * 2006-09-21 2009-04-28 Scripps Research Inst Expresion geneticamente programada de proteinas selectivamente sulfatadas en eubacterias.
JP2010506591A (ja) 2006-10-18 2010-03-04 ザ スクリップス リサーチ インスティテュート 哺乳動物細胞中の蛋白質への非天然アミノ酸の遺伝的組込み
CN104163864B (zh) 2007-03-30 2017-08-01 Ambrx公司 经修饰fgf‑21多肽和其用途
WO2008137471A2 (en) 2007-05-02 2008-11-13 Ambrx, Inc. Modified interferon beta polypeptides and their uses
CN102203257B (zh) * 2007-10-25 2014-01-08 斯克利普斯研究院 3-氨基酪氨酸遗传掺入还原酶
WO2009059056A2 (en) * 2007-11-02 2009-05-07 The Scripps Research Institute A genetically encoded boronate amino acid
US9150849B2 (en) 2007-11-02 2015-10-06 The Scripps Research Institute Directed evolution using proteins comprising unnatural amino acids
US8946148B2 (en) 2007-11-20 2015-02-03 Ambrx, Inc. Modified insulin polypeptides and their uses
JP2011527886A (ja) 2007-12-11 2011-11-10 ザ スクリプス リサーチ インスティチュート メタノール資化性酵母ピキア・パストリスにおけるインビボ非天然アミノ酸発現
BRPI0906388A2 (pt) * 2008-02-08 2015-07-07 Scripps Research Inst Quebra de tolerância imunológica com um aminoácido não natural geneticamente codificado
SG188143A1 (en) 2008-02-08 2013-03-28 Ambrx Inc Modified leptin polypeptides and their uses
US20110076718A1 (en) * 2008-02-27 2011-03-31 The Scripps Research Institute In vivo incorporation of an unnatural amino acid comprising a 1,2-aminothiol group
ES2614078T3 (es) 2008-03-31 2017-05-29 Pacific Biosciences Of California, Inc. Generación de polimerasas modificadas para precisión mejorada en secuenciación de una única molécula
NZ600382A (en) 2008-07-23 2013-11-29 Ambrx Inc Modified bovine G-CSF polypeptides and their uses
HUE035168T2 (en) 2008-09-26 2018-05-02 Ambrx Inc Modified animal erythropoietin polypeptides and their applications
EA201170493A1 (ru) 2008-09-26 2011-10-31 Амбркс, Инк. Микроорганизмы и вакцины, зависимые от репликации неприродных аминокислот
CN102307905B (zh) * 2008-12-10 2015-11-25 斯克利普斯研究院 利用化学反应性非天然氨基酸产生载体-肽偶联物
US20090197339A1 (en) * 2008-12-10 2009-08-06 The Scripps Research Institute In vivo unnatural amino acid expression in the methylotrophic yeast pichia pastoris
CN102753573A (zh) 2009-12-21 2012-10-24 Ambrx公司 经过修饰的牛促生长素多肽和其用途
EP2805965A1 (de) 2009-12-21 2014-11-26 Ambrx, Inc. Modifizierte Schweine-Somatotropin-Polypeptide und deren Verwendungen
US8980253B2 (en) 2010-04-26 2015-03-17 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-tRNA synthetase
ES2638311T3 (es) 2010-04-27 2017-10-19 Atyr Pharma, Inc. Descubrimiento innovador de composiciones terapéuticas, diagnósticas y de anticuerpos relacionadas con fragmentos de proteína de treonil ARNt sintetasas
US8961960B2 (en) 2010-04-27 2015-02-24 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl tRNA synthetases
US8993723B2 (en) 2010-04-28 2015-03-31 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl-tRNA synthetases
WO2011139907A2 (en) 2010-04-29 2011-11-10 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases
AU2011248490B2 (en) 2010-04-29 2016-11-10 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Asparaginyl tRNA synthetases
WO2011150279A2 (en) 2010-05-27 2011-12-01 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-trna synthetases
EP2566496B1 (de) 2010-05-03 2018-02-28 aTyr Pharma, Inc. Innovative entdeckung therapeutischer, diagnostischer und antikörperhaltiger zusammensetzungen im zusammenhang mit proteinfragmenten von methionyl-trna-synthetasen
CN103108655B (zh) 2010-05-03 2017-04-05 Atyr 医药公司 与丝氨酰‑tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
US9034321B2 (en) 2010-05-03 2015-05-19 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases
WO2011139986A2 (en) 2010-05-03 2011-11-10 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-trna synthetases
US9062302B2 (en) 2010-05-04 2015-06-23 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-tRNA synthetase complex
EP2566492B1 (de) 2010-05-04 2016-10-26 aTyr Pharma, Inc. Innovative entdeckung therapeutischer zusammensetzungen im zusammenhang mit proteinfragmenten von glutamyl-prolyl-trna-synthetasen
AU2011252990B2 (en) 2010-05-14 2017-04-20 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-tRNA synthetases
CA2799480C (en) 2010-05-17 2020-12-15 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-trna synthetases
JP5906237B2 (ja) * 2010-06-01 2016-04-20 エータイアー ファーマ， インコーポレイテッド リジルｔＲＮＡ合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
AU2011279392C1 (en) 2010-07-12 2017-06-15 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-tRNA synthetases
US8999321B2 (en) 2010-07-12 2015-04-07 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases
EA030418B1 (ru) 2010-07-12 2018-08-31 ЭйТИР ФАРМА, ИНК. ТЕРАПЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И СПОСОБ ДЛЯ ЛЕЧЕНИЯ ВОСПАЛИТЕЛЬНОГО ЗАБОЛЕВАНИЯ, ПОЛИПЕПТИД АМИНОАЦИЛ-тРНК-СИНТЕТАЗЫ (AARS)
WO2012021247A2 (en) 2010-07-12 2012-02-16 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases
US9567386B2 (en) 2010-08-17 2017-02-14 Ambrx, Inc. Therapeutic uses of modified relaxin polypeptides
SI3572091T1 (sl) 2010-08-17 2024-07-31 Ambrx, Inc., Modificirani polipeptidi relaksina in njihova uporaba
AU2011293294B2 (en) 2010-08-25 2016-03-24 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Tyrosyl-tRNA synthetases
TWI480288B (zh) 2010-09-23 2015-04-11 Lilly Co Eli 牛顆粒細胞群落刺激因子及其變體之調配物
US9399770B2 (en) 2010-10-06 2016-07-26 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tryptophanyl-tRNA synthetases
US20130078671A1 (en) * 2011-03-25 2013-03-28 The Texas A&M University System Incorporation of two different noncanonical amino acids into a single protein
CA2853829C (en) 2011-07-22 2023-09-26 President And Fellows Of Harvard College Evaluation and improvement of nuclease cleavage specificity
WO2013022982A2 (en) 2011-08-09 2013-02-14 Atyr Pharma, Inc. Pegylated tyrosyl-trna synthetase polypeptides
WO2013086216A1 (en) 2011-12-06 2013-06-13 Atyr Pharma, Inc. Improved aspartyl-trna synthetases
WO2013086228A1 (en) 2011-12-06 2013-06-13 Atyr Pharma, Inc. Pegylated aspartyl-trna synthetase polypeptides
CN102517241B (zh) * 2011-12-19 2013-06-19 中国药科大学 一种含有d型氨基酸的双羰基还原酶的突变体的制备方法
WO2013115926A2 (en) 2011-12-29 2013-08-08 Atyr Pharma, Inc. Aspartyl-trna synthetase-fc conjugates
WO2013171485A1 (en) * 2012-05-18 2013-11-21 Medical Research Council Methods of incorporating an amino acid comprising a bcn group into a polypeptide using an orthogonal codon encoding it and an orthorgonal pylrs synthase.
UY35368A (es) 2013-03-08 2014-10-31 Irm Llc Péptidos y composiciones para el tratamiento de daño articular
EP2970921B1 (de) 2013-03-15 2018-09-19 aTyr Pharma, Inc. Histidyl-trna-synthetase-fc-konjugate
CN104099360A (zh) * 2013-04-12 2014-10-15 北京大学 非天然氨基酸标记的目的蛋白或肽的制备
WO2015009948A1 (en) 2013-07-19 2015-01-22 Regents Of The University Of California Milk fat globule epidermal growth factor 8 regulates fatty acid uptake
US9163284B2 (en) 2013-08-09 2015-10-20 President And Fellows Of Harvard College Methods for identifying a target site of a Cas9 nuclease
US9359599B2 (en) 2013-08-22 2016-06-07 President And Fellows Of Harvard College Engineered transcription activator-like effector (TALE) domains and uses thereof
US9322037B2 (en) 2013-09-06 2016-04-26 President And Fellows Of Harvard College Cas9-FokI fusion proteins and uses thereof
US9737604B2 (en) 2013-09-06 2017-08-22 President And Fellows Of Harvard College Use of cationic lipids to deliver CAS9
US9340799B2 (en) 2013-09-06 2016-05-17 President And Fellows Of Harvard College MRNA-sensing switchable gRNAs
US20150166985A1 (en) 2013-12-12 2015-06-18 President And Fellows Of Harvard College Methods for correcting von willebrand factor point mutations
EP3177718B1 (de) 2014-07-30 2022-03-16 President and Fellows of Harvard College Cas9-proteine mit ligandenabhängigen inteinen
SMT202100388T1 (it) 2014-10-24 2021-09-14 Bristol Myers Squibb Co Polipeptidi fgf-21 modificati e loro usi
GEAP202215554A (en) 2015-07-30 2022-06-10 Macrogenics Inc Pd-1-binding molecules and methods of use thereof
SG10202104041PA (en) 2015-10-23 2021-06-29 Harvard College Nucleobase editors and uses thereof
MX2018007089A (es) 2015-12-14 2019-01-30 Macrogenics Inc Moleculas biespecificas que tienen inmunorreactividad con pd-1 y ctla-4, y metodos de uso de las mismas.
EP3494215A1 (de) 2016-08-03 2019-06-12 President and Fellows of Harvard College Adenosenukleobaseneditoren und verwendungen davon
CN109804066A (zh) 2016-08-09 2019-05-24 哈佛大学的校长及成员们 可编程cas9-重组酶融合蛋白及其用途
WO2018039438A1 (en) 2016-08-24 2018-03-01 President And Fellows Of Harvard College Incorporation of unnatural amino acids into proteins using base editing
AU2017342543B2 (en) 2016-10-14 2024-06-27 President And Fellows Of Harvard College AAV delivery of nucleobase editors
AU2017357785A1 (en) 2016-11-14 2019-04-11 Novartis Ag Methods and compositions for treatment of cartilage damage and arthritis
WO2018119359A1 (en) 2016-12-23 2018-06-28 President And Fellows Of Harvard College Editing of ccr5 receptor gene to protect against hiv infection
BR112019016139A2 (pt) 2017-02-08 2020-04-07 Bristol-Myers Squibb Company polipeptídio de relaxina modificada compreendendo um melhorador farmacocinético e usos do mesmo
CN110662556A (zh) 2017-03-09 2020-01-07 哈佛大学的校长及成员们 癌症疫苗
US11898179B2 (en) 2017-03-09 2024-02-13 President And Fellows Of Harvard College Suppression of pain by gene editing
KR20190127797A (ko) 2017-03-10 2019-11-13 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 시토신에서 구아닌으로의 염기 편집제
IL269458B2 (en) 2017-03-23 2024-02-01 Harvard College Nucleic base editors that include nucleic acid programmable DNA binding proteins
US11767520B2 (en) 2017-04-20 2023-09-26 Atyr Pharma, Inc. Compositions and methods for treating lung inflammation
WO2018209320A1 (en) 2017-05-12 2018-11-15 President And Fellows Of Harvard College Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation
WO2019023680A1 (en) 2017-07-28 2019-01-31 President And Fellows Of Harvard College METHODS AND COMPOSITIONS FOR EVOLUTION OF BASIC EDITORS USING PHAGE-ASSISTED CONTINUOUS EVOLUTION (PACE)
US11319532B2 (en) 2017-08-30 2022-05-03 President And Fellows Of Harvard College High efficiency base editors comprising Gam
WO2019079347A1 (en) 2017-10-16 2019-04-25 The Broad Institute, Inc. USES OF BASIC EDITORS ADENOSINE
US12406749B2 (en) 2017-12-15 2025-09-02 The Broad Institute, Inc. Systems and methods for predicting repair outcomes in genetic engineering
LU100734B1 (en) 2018-03-15 2019-10-01 Univ Hamburg Synthetic transfer RNA with extended anticodon loop
JP7578490B2 (ja) 2018-03-15 2024-11-06 アークタラス テラピュウティクス、インク 拡張アンチコドンループを有する合成転移ｒｎａ
CN112314052A (zh) 2018-03-27 2021-02-02 艾斯彼控股,耐催德点火器有限公司的商定名称 用于灶具的热表面点火器
BR112020022288A2 (pt) 2018-05-01 2021-02-23 Ambrx, Inc. método para otimizar a expressão de anticorpos
US12157760B2 (en) 2018-05-23 2024-12-03 The Broad Institute, Inc. Base editors and uses thereof
EP3820495A4 (de) 2018-07-09 2022-07-20 The Broad Institute Inc. Rna-programmierbare epigenetische rna-modifikatoren und deren verwendungen
PL3849614T3 (pl) 2018-09-11 2024-04-22 Ambrx, Inc. Koniugaty polipeptydu interleukiny-2 i ich zastosowania
CN113366015A (zh) 2018-10-19 2021-09-07 Ambrx公司 白细胞介素-10多肽缀合物、其二聚体及其用途
GB201817444D0 (en) 2018-10-26 2018-12-12 Res & Innovation Uk Methods and compositions
WO2020092453A1 (en) 2018-10-29 2020-05-07 The Broad Institute, Inc. Nucleobase editors comprising geocas9 and uses thereof
US12351837B2 (en) 2019-01-23 2025-07-08 The Broad Institute, Inc. Supernegatively charged proteins and uses thereof
AU2020242032A1 (en) 2019-03-19 2021-10-07 Massachusetts Institute Of Technology Methods and compositions for editing nucleotide sequences
CN111718920B (zh) * 2019-03-19 2021-05-07 宁波鲲鹏生物科技有限公司 在蛋白中高效引入赖氨酸衍生物的氨酰基-tRNA合成酶
WO2020208169A1 (en) 2019-04-11 2020-10-15 Universität Hamburg Synthetic transfer rna with extended anticodon loop
LU101182B1 (en) * 2019-04-11 2020-10-12 Univ Hamburg Synthetic transfer RNA with extended anticodon loop
US12473543B2 (en) 2019-04-17 2025-11-18 The Broad Institute, Inc. Adenine base editors with reduced off-target effects
CN110172467B (zh) * 2019-05-24 2021-03-16 浙江大学 一种利用嵌合设计方法构建正交的氨酰-tRNA合成酶/tRNA体系
US12435330B2 (en) 2019-10-10 2025-10-07 The Broad Institute, Inc. Methods and compositions for prime editing RNA
AU2021233909A1 (en) 2020-03-11 2022-09-29 Ambrx, Inc. Interleukin-2 polypeptide conjugates and methods of use thereof
JP2023525304A (ja) 2020-05-08 2023-06-15 ザ ブロード インスティテュート，インコーポレーテッド 標的二本鎖ヌクレオチド配列の両鎖同時編集のための方法および組成物
CN114250243B (zh) * 2020-09-24 2024-05-03 深圳华大生命科学研究院 一种检测极端嗜盐生物中氨酰-tRNA合成酶和tRNA活性的系统及方法
WO2023281484A1 (en) 2021-07-09 2023-01-12 Bright Peak Therapeutics Ag Synthetic il-7 and il-7 immunocytokines
WO2023281480A1 (en) 2021-07-09 2023-01-12 Bright Peak Therapeutics Ag Conjugates of checkpoint inhibitors with il-2, and uses thereof
JP2024526297A (ja) 2021-07-09 2024-07-17 ブライト ピーク セラピューティクス エージー 抗体コンジュゲートおよびその製造
US20230201365A1 (en) 2021-07-09 2023-06-29 Bright Peak Therapeutics Ag Modified cd20 antibodies and uses thereof
EP4366779A1 (de) 2021-07-09 2024-05-15 Bright Peak Therapeutics AG Modifizierte tnf-antikörper und verwendungen davon
WO2023069816A2 (en) 2021-09-20 2023-04-27 The Broad Institute, Inc. Compositions and methods for multiplex decoding of quadruplet codons
WO2023161857A1 (en) 2022-02-23 2023-08-31 Bright Peak Therapeutics Ag Bifunctional cytokine compositions
US12383631B2 (en) 2022-02-23 2025-08-12 Bright Peak Therapeutics Ag Immune antigen specific IL-18 immunocytokines and uses thereof
CN114908066B (zh) * 2022-05-17 2024-01-23 杭州嵌化合生医药科技有限公司 一种正交翻译系统及其在再分配密码子恢复ptc疾病中功能蛋白表达方面的应用
WO2024091824A1 (en) 2022-10-26 2024-05-02 Ada Forsyth Institute, Inc. Differentiation and reprogramming of chondrocyte
WO2024150175A1 (en) 2023-01-11 2024-07-18 Bright Peak Therapeutics Ag Conditionally activated proteins and methods of use
CN115975978B (zh) * 2023-02-01 2023-08-01 珠海宝锐生物科技有限公司 Bst DNA聚合酶大片段突变体及其应用
WO2024241086A1 (en) 2023-05-24 2024-11-28 Ambrx, Inc. Pegylated bovine interferon lambda and methods of use thereof
US20250186597A1 (en) 2023-08-23 2025-06-12 Bright Peak Therapeutics Ag Targeted immune activation with il-18 immunocytokines
US20250197467A1 (en) 2023-08-23 2025-06-19 Bright Peak Therapeutics Ag Activatable il-18 immunocytokines and uses thereof

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998050552A1 (en) 1997-05-06 1998-11-12 Zymogenetics, Inc. Novel tumor antigens
JP2005503120A (ja) * 2001-03-27 2005-02-03 マサチューセッツ　インスティテュート　オブ　テクノロジー Ｆｇｆダイマー化に関する方法及び生成物
IL158419A0 (en) * 2001-04-19 2004-05-12 Scripps Research Inst Methods and composition for the production of orthoganal trna-aminoacyl trna synthetase pairs
CA2463899A1 (en) * 2001-10-17 2003-04-24 Zymogenetics, Inc. Secreted protein, ztnf9
DE60327369D1 (de) 2002-10-16 2009-06-04 Scripps Research Inst Stellenspezifischer einbau von ketoaminosäuren in proteine
ES2333422T3 (es) * 2002-10-16 2010-02-22 The Scripps Research Institute Sintesis de glicoproteinas.
JP4486893B2 (ja) * 2002-12-22 2010-06-23 ザ スクリップス リサーチ インスティテュート タンパク質アレイ
EP1613735B1 (de) * 2003-04-17 2012-01-25 The Scripps Research Institute Ausweitung des eukaryotischen genetischen codes
EP2410331B1 (de) * 2003-06-18 2015-09-23 The Scripps Research Institute Aminoacyl-tRNA Synthetase zur Aminoacylierung von tRNA mit unnatürlichen Aminosäuren
US7527943B2 (en) * 2003-07-07 2009-05-05 The Scripps Research Institute Compositions of orthogonal glutamyl-tRNA and aminoacyl-tRNA synthetase pairs and uses thereof
PT1914314E (pt) * 2003-07-07 2010-09-08 Scripps Research Inst Composições de pares ortogonais de lisil-arnt e aminoacil-arnt-sintetase e suas utilizações
EP1704242A4 (de) * 2003-07-07 2008-06-18 Scripps Research Inst ZUSAMMENSETZUNGEN MIT PAAREN VON ORTHOGONALER LEUCYL-tRNA UND AMINOACYL-tRNA-SYNTHETASE UND VERWENDUNGEN DAVON
JP5657850B2 (ja) * 2003-10-14 2015-01-21 ザ スクリプス リサーチ インスティテュート 酸化還元機能性アミノ酸のタンパク質への部位特異的組み入れ
EP1725251A4 (de) * 2003-12-18 2009-07-01 Scripps Research Inst Selektive einarbeitung von 5-hydroxytryptophan in proteine in säugetierzellen
US7399619B2 (en) * 2004-05-25 2008-07-15 The Scripps Research Institute Site specific incorporation of heavy atom-containing unnatural amino acids into proteins for structure determination
US20060134746A1 (en) * 2004-09-21 2006-06-22 The Scripps Research Institute Adding photoregulated amino acids to the genetic code
EP2770053B1 (de) * 2004-09-21 2018-02-21 The Scripps Research Institute In-vivo-Einbringung von Alkynyl-Aminosäuren in Proteine in Eubakterien
JP2008513806A (ja) * 2004-09-22 2008-05-01 ザ スクリップス リサーチ インスティテュート Ｎｍｒ試験のための蛋白質の部位特異的標識
EP1809758A4 (de) * 2004-10-20 2009-04-01 Scripps Research Inst Stellenspezifischer in-vivo-einbau von n-acetylgalactosamin-aminosäuren in eubakterien
US8216804B2 (en) * 2004-10-27 2012-07-10 The Scripps Research Institute Orthogonal translation components for the in vivo incorporation of unnatural amino acids
FR2888097B1 (fr) * 2005-07-06 2007-10-05 Oreal Dispositif de conditionnement et d'application comportant un organe d'essorage
BRPI0617191A2 (pt) * 2005-10-12 2011-07-19 Scripps Research Inst modificação pós-traducional de polipeptìdeos expressos em fagos
PL1991680T3 (pl) * 2006-03-09 2014-01-31 Scripps Research Inst Układ do ekspresji ortogonalnych składników translacji w eubakteryjnych komórkach gospodarza
MX2008011669A (es) * 2006-03-16 2008-09-22 Scripps Research Inst Expresion programada geneticamente de proteinas que contienen el aminoacido no natural fenilselenocisteina.
EP2018429A4 (de) * 2006-05-23 2010-07-14 Scrips Res Inst Genetisch kodierte fluoreszente cumarin-aminosäuren
MX2009002987A (es) 2006-09-21 2009-04-28 Scripps Research Inst Expresion geneticamente programada de proteinas selectivamente sulfatadas en eubacterias.
JP2010506591A (ja) * 2006-10-18 2010-03-04 ザ スクリップス リサーチ インスティテュート 哺乳動物細胞中の蛋白質への非天然アミノ酸の遺伝的組込み
TWI334126B (en) * 2007-07-17 2010-12-01 Au Optronics Corp Voltage adjusting circuit, method, and display apparatus having the same
CN102203257B (zh) * 2007-10-25 2014-01-08 斯克利普斯研究院 3-氨基酪氨酸遗传掺入还原酶
US9150849B2 (en) * 2007-11-02 2015-10-06 The Scripps Research Institute Directed evolution using proteins comprising unnatural amino acids
WO2009059056A2 (en) * 2007-11-02 2009-05-07 The Scripps Research Institute A genetically encoded boronate amino acid
WO2009064416A2 (en) 2007-11-15 2009-05-22 The Scripps Research Institute Genetic incorporation of an alpha-hydroxy acid into proteins to generate ester backbone linkages at defined sites
BRPI0906388A2 (pt) * 2008-02-08 2015-07-07 Scripps Research Inst Quebra de tolerância imunológica com um aminoácido não natural geneticamente codificado
US20110076718A1 (en) 2008-02-27 2011-03-31 The Scripps Research Institute In vivo incorporation of an unnatural amino acid comprising a 1,2-aminothiol group
US20090197339A1 (en) * 2008-12-10 2009-08-06 The Scripps Research Institute In vivo unnatural amino acid expression in the methylotrophic yeast pichia pastoris

Also Published As

Publication number Publication date
SI1666604T1 (sl) 2008-08-31
EP1666604A1 (de) 2006-06-07
US7638297B2 (en) 2009-12-29
PT1666604E (pt) 2008-05-19
EP1649004A2 (de) 2006-04-26
US20070042461A1 (en) 2007-02-22
MXPA06000242A (es) 2006-04-07
US20120129215A1 (en) 2012-05-24
BRPI0412272A (pt) 2006-09-05
WO2005019415A2 (en) 2005-03-03
ES2301099T3 (es) 2008-06-16
ATE471385T1 (de) 2010-07-15
US20060177900A1 (en) 2006-08-10
US20100291559A1 (en) 2010-11-18
WO2005019415A3 (en) 2007-01-25
PT1914314E (pt) 2010-09-08
DE602004011789T2 (de) 2009-02-12
CN101076598A (zh) 2007-11-21
US8030028B2 (en) 2011-10-04
US7575895B2 (en) 2009-08-18
DE602004011789D1 (de) 2008-03-27
JP5192150B2 (ja) 2013-05-08
US8669073B2 (en) 2014-03-11
JP2007529998A (ja) 2007-11-01
DE602004027770D1 (de) 2010-07-29
JP2011101656A (ja) 2011-05-26
AU2004267359A1 (en) 2005-03-03
EP1649004A4 (de) 2008-04-09
EP1666604B1 (de) 2008-02-13
AU2004267359B2 (en) 2010-09-09
CN101076598B (zh) 2012-07-25
CA2531146A1 (en) 2005-03-03

Similar Documents

Publication Publication Date Title
ATE386133T1 (de) Zusammensetzungen der orthogonalen lysyl-trna und aminoacyl-trna synthetase paaren und ihre verwendungen
CY1110483T1 (el) Θεσεως ειδικη ενσωματωση των κετο αμινοξεων εντος πρωτεϊνων
ATE541934T1 (de) Zusammensetzungen von aminoacyl-trna-synthetase und verwendungen davon
MX2008002149A (es) Composiciones de arnt y sus usos.
WO2005007870A3 (en) COMPOSITIONS OF ORTHOGONAL LEUCYL-tRNA AND AMINOACYL-tRNA SYNTHETASE PAIRS AND USES THEREOF
WO2005007624A3 (en) Compositions of orthogonal glutamyl-trna and aminoacyl trna synthetase pairs and uses thereof
WO2006034410A3 (en) Adding photoregulated amino acids to the genetic code
WO2005038002A3 (en) Site-specific incorporation of redox active amino acids into proteins
WO2002086075A3 (en) Methods and composition for the production of orthoganal trna-aminoacyltrna synthetase pairs
EA202191033A1 (ru) Программируемое редактирование оснований днк посредством слитых белков nme2cas9-дезаминаза
MX2007003142A (es) Incorporacion in vivo de alquinil aminoacidos a proteinas en eubacterias.
ATE542888T1 (de) Standortspezifische inkorporation nicht natürlicher aminosäuren in wirbeltierzellen
ATE387502T1 (de) Hybride expression von neisseria proteinen
DK1792976T3 (da) Mikroorganisme af slægten Corynebacterium med forhøjet L-lysin-produktionsevne og fremgangsmåde til fremstilling af L-lysin dermed
EP1914314A3 (de) Zusammensetzungen aus orthogonalen Lysyl-TRNA- und Aminoacyl-TRNA-Synthetasepaaren und deren Verwendung
BRPI0408023A (pt) métodos para previnir gliconoilação de proteìnas
AU300871S (en) Jig saw

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1666604

Country of ref document: EP